×
The Vasopressin V1b Receptor Antagonist SSR149415 in the Treatment of Major Depressive and Generalized Anxiety Disorders: Results From 4 Randomized, Double-Blind, Placebo-Controlled Studies PDF
$ 40.00
The Vasopressin V1b Receptor Antagonist SSR149415 in the Treatment of Major Depressive and Generalized Anxiety Disorders: Results From 4 Randomized, Double-Blind, Placebo-Controlled Studies PDF quantity
$ 40.00
×
Neurological and Psychiatric Manifestations of Cerebral Arteriovenous Malformation: A Case of Hemichorea and Depression PDF
$ 40.00
Neurological and Psychiatric Manifestations of Cerebral Arteriovenous Malformation: A Case of Hemichorea and Depression PDF quantity
$ 40.00
×
Health-Related Quality-of-Life Measure Enhances Acute Treatment Response Prediction in Depressed Inpatients PDF
$ 40.00
Health-Related Quality-of-Life Measure Enhances Acute Treatment Response Prediction in Depressed Inpatients PDF quantity
$ 40.00
×
The Dual Advantage of Allopurinol in a Patient With Severe Mania and Gout PDF
$ 40.00
The Dual Advantage of Allopurinol in a Patient With Severe Mania and Gout PDF quantity
$ 40.00
×
Greater Social Functioning Associated With Lower Depressive Symptomatology Among Black Belt African Americans Enrolled in the Southeastern Collaboration to Improve Blood Pressure Control Study PDF
$ 40.00
Greater Social Functioning Associated With Lower Depressive Symptomatology Among Black Belt African Americans Enrolled in the Southeastern Collaboration to Improve Blood Pressure Control Study PDF quantity
$ 40.00
×
Predictors of Persistence of Comorbid Generalized Anxiety Disorder Among Veterans With Major Depressive Disorder PDF
$ 40.00
Predictors of Persistence of Comorbid Generalized Anxiety Disorder Among Veterans With Major Depressive Disorder PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart